Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
101.66
-4.24 (-4.00%)
Nov 17, 2025, 2:14 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 28.03 billion as of November 14, 2025. Its market cap has increased by 56.52% in one year.
Market Cap
28.03B
Enterprise Value
27.07B
Revenue
742.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
101.66
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 28.03B, an increase of 56.59%. That is a compound annual growth rate of 8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 28.03B | 69.96% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | 15.53B | -13.27% |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |